NCCN Guidelines Insights: Kidney Cancer, Version 2.2020.
Publication
, Journal Article
Motzer, RJ; Jonasch, E; Michaelson, MD; Nandagopal, L; Gore, JL; George, S; Alva, A; Haas, N; Harrison, MR; Plimack, ER; Sosman, J; Agarwal, N ...
Published in: J Natl Compr Canc Netw
November 1, 2019
The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal cell carcinoma, and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize the NCCN Kidney Cancer Panel discussions for the 2020 update to the guidelines regarding initial management and first-line systemic therapy options for patients with advanced clear cell renal cell carcinoma.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
November 1, 2019
Volume
17
Issue
11
Start / End Page
1278 / 1285
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Kidney Neoplasms
- Humans
- Clinical Decision-Making
- Carcinoma, Renal Cell
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Motzer, R. J., Jonasch, E., Michaelson, M. D., Nandagopal, L., Gore, J. L., George, S., … Zuccarino-Catania, G. (2019). NCCN Guidelines Insights: Kidney Cancer, Version 2.2020. J Natl Compr Canc Netw, 17(11), 1278–1285. https://doi.org/10.6004/jnccn.2019.0054
Motzer, Robert J., Eric Jonasch, M Dror Michaelson, Lakshminarayanan Nandagopal, John L. Gore, Saby George, Ajjai Alva, et al. “NCCN Guidelines Insights: Kidney Cancer, Version 2.2020.” J Natl Compr Canc Netw 17, no. 11 (November 1, 2019): 1278–85. https://doi.org/10.6004/jnccn.2019.0054.
Motzer RJ, Jonasch E, Michaelson MD, Nandagopal L, Gore JL, George S, et al. NCCN Guidelines Insights: Kidney Cancer, Version 2.2020. J Natl Compr Canc Netw. 2019 Nov 1;17(11):1278–85.
Motzer, Robert J., et al. “NCCN Guidelines Insights: Kidney Cancer, Version 2.2020.” J Natl Compr Canc Netw, vol. 17, no. 11, Nov. 2019, pp. 1278–85. Pubmed, doi:10.6004/jnccn.2019.0054.
Motzer RJ, Jonasch E, Michaelson MD, Nandagopal L, Gore JL, George S, Alva A, Haas N, Harrison MR, Plimack ER, Sosman J, Agarwal N, Bhayani S, Choueiri TK, Costello BA, Derweesh IH, Gallagher TH, Hancock SL, Kyriakopoulos C, LaGrange C, Lam ET, Lau C, Lewis B, Manley B, McCreery B, McDonald A, Mortazavi A, Pierorazio PM, Ponsky L, Redman BG, Somer B, Wile G, Dwyer MA, CGC, Hammond LJ, Zuccarino-Catania G. NCCN Guidelines Insights: Kidney Cancer, Version 2.2020. J Natl Compr Canc Netw. 2019 Nov 1;17(11):1278–1285.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
November 1, 2019
Volume
17
Issue
11
Start / End Page
1278 / 1285
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Kidney Neoplasms
- Humans
- Clinical Decision-Making
- Carcinoma, Renal Cell
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis